| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.996 | 0.001 | 0.996 | Hypoxia-inducible factor 1 alpha inhibitor | 0.996 0.001 DBMET00759 0.995 0.001 DBMET02361 0.801 0.003 DBMET02362 0.778 0.003 DBMET02370 0.798 0.003 DBMET02367 0.306 0.063 DBMET02369 | ||
| 0.989 | 0.003 | 0.995 | Antiinflammatory | 0.987 0.003 DBMET00759 0.995 0.003 DBMET02361 0.956 0.004 DBMET02362 0.975 0.004 DBMET02370 0.974 0.004 DBMET02367 0.75 0.022 DBMET02369 | DBMET02361 | |
| 0.956 | 0.001 | 0.97 | Antipruritic | 0.926 0.002 DBMET00759 0.97 0.001 DBMET02361 0.525 0.004 DBMET02362 0.597 0.004 DBMET02370 0.6 0.004 DBMET02367 | DBMET02361 | |
| 0.955 | 0.004 | 0.966 | Toll-Like receptor agonist | 0.948 0.004 DBMET00759 0.966 0.004 DBMET02361 0.509 0.03 DBMET02362 0.899 0.004 DBMET02370 0.431 0.049 DBMET02367 | DBMET02361 | |
| 0.955 | 0.004 | 0.966 | Toll-Like receptor 7 agonist | 0.948 0.004 DBMET00759 0.966 0.003 DBMET02361 0.522 0.028 DBMET02362 0.901 0.004 DBMET02370 0.442 0.046 DBMET02367 | DBMET02361 | |
| 0.909 | 0 | 0.94 | Lipocortins synthesis agonist | 0.863 0 DBMET00759 0.94 0 DBMET02361 0.325 0 DBMET02362 0.546 0 DBMET02370 0.348 0 DBMET02367 0.137 0.002 DBMET02369 | DBMET02361 | |
| 0.863 | 0 | 0.973 | Corticosteroid-like | 0.812 0 DBMET00759 0.973 0 DBMET02361 0.294 0.001 DBMET02362 0.502 0 DBMET02370 0.336 0.001 DBMET02367 0.066 0.002 DBMET02369 | DBMET02361 | |
| 0.86 | 0 | 0.923 | Glucocorticoid agonist | 0.839 0 DBMET00759 0.923 0 DBMET02361 0.588 0.001 DBMET02362 0.742 0.001 DBMET02370 0.647 0.001 DBMET02367 0.079 0.003 DBMET02369 | DBMET02361 | |
| 0.827 | 0.003 | 0.857 | Immunosuppressant | 0.817 0.003 DBMET00759 0.857 0.003 DBMET02361 0.685 0.005 DBMET02362 0.778 0.004 DBMET02370 0.724 0.005 DBMET02367 0.504 0.032 DBMET02369 | DBMET02361 | |
| 0.815 | 0 | 0.815 | Arachidonic acid antagonist | 0.693 0 DBMET00759 0.754 0 DBMET02361 0.399 0 DBMET02362 0.37 0.001 DBMET02370 0.4 0 DBMET02367 0.28 0.003 DBMET02369 | ||
| 0.776 | 0.014 | 0.917 | Transcription factor NF kappa B inhibitor | 0.773 0.015 DBMET00759 0.917 0.005 DBMET02361 0.541 0.039 DBMET02362 0.886 0.007 DBMET02370 0.82 0.011 DBMET02367 0.717 0.019 DBMET02369 | DBMET02361 | |
| 0.752 | 0.001 | 0.902 | Glucocorticoid antagonist | 0.736 0.001 DBMET00759 0.902 0.001 DBMET02361 0.512 0.002 DBMET02362 0.308 0.003 DBMET02370 0.631 0.002 DBMET02367 0.122 0.004 DBMET02369 | DBMET02361 | |
| 0.619 | 0.003 | 0.946 | Androgen antagonist | 0.58 0.003 DBMET00759 0.946 0.002 DBMET02361 0.347 0.006 DBMET02362 0.224 0.011 DBMET02370 0.697 0.003 DBMET02367 0.1 0.047 DBMET02369 | DBMET02361 | |
| 0.523 | 0.002 | 0.587 | Androgen agonist | 0.466 0.002 DBMET00759 0.587 0.002 DBMET02361 0.215 0.004 DBMET02362 0.2 0.005 DBMET02370 0.282 0.003 DBMET02367 0.092 0.018 DBMET02369 | DBMET02361 | |
| 0.44 | 0.006 | 0.504 | Lipocortins synthesis antagonist | 0.465 0.005 DBMET00759 0.504 0.004 DBMET02361 0.4 0.009 DBMET02362 0.397 0.009 DBMET02370 0.466 0.005 DBMET02367 0.349 0.014 DBMET02369 | DBMET02361 | |
| 0.442 | 0.042 | 0.518 | Thioredoxin glutathione reductase inhibitor | 0.459 0.038 DBMET00759 0.518 0.026 DBMET02362 | DBMET02362 | |
| 0.293 | 0.021 | 0.46 | Interferon gamma antagonist | 0.329 0.016 DBMET00759 0.46 0.008 DBMET02361 0.218 0.035 DBMET02362 0.276 0.024 DBMET02370 0.411 0.01 DBMET02367 0.212 0.037 DBMET02369 | DBMET02361 | |
| 0.316 | 0.065 | 0.374 | Sodium/bile acid cotransporter inhibitor | 0.374 0.027 DBMET00759 0.374 0.027 DBMET02361 0.269 0.108 DBMET02362 0.309 0.071 DBMET02370 0.361 0.033 DBMET02367 0.256 0.122 DBMET02369 | DBMET02361 | |
| 0.373 | 0.127 | 0.804 | Apoptosis agonist | 0.452 0.09 DBMET00759 0.486 0.079 DBMET02361 0.695 0.032 DBMET02362 0.345 0.142 DBMET02370 0.804 0.016 DBMET02367 0.706 0.03 DBMET02369 | DBMET02367 | |
| 0.268 | 0.047 | 0.477 | Nitric oxide antagonist | 0.306 0.039 DBMET00759 0.292 0.042 DBMET02361 0.399 0.026 DBMET02362 0.329 0.035 DBMET02370 0.446 0.02 DBMET02367 0.477 0.018 DBMET02369 | DBMET02369 | |
| 0.336 | 0.136 | 0.336 | Transcription factor inhibitor | 0.284 0.164 DBMET00759 0.225 0.205 DBMET02362 | ||
| 0.257 | 0.062 | 0.397 | DNA synthesis inhibitor | 0.269 0.056 DBMET00759 0.397 0.022 DBMET02361 0.196 0.129 DBMET02362 0.24 0.074 DBMET02370 0.354 0.029 DBMET02367 0.185 0.146 DBMET02369 | DBMET02361 | |
| 0.192 | 0.005 | 0.229 | Anabolic | 0.198 0.004 DBMET00759 0.229 0.002 DBMET02361 0.167 0.011 DBMET02362 0.189 0.005 DBMET02370 0.205 0.004 DBMET02367 0.167 0.01 DBMET02369 | DBMET02361 | |
| 0.222 | 0.052 | 0.442 | P-glycoprotein inhibitor | 0.253 0.04 DBMET00759 0.203 0.062 DBMET02361 0.438 0.012 DBMET02362 0.442 0.012 DBMET02367 0.251 0.041 DBMET02369 | DBMET02367 | |
| 0.204 | 0.039 | 0.465 | NOS3 expression enhancer | 0.203 0.04 DBMET00759 0.465 0.005 DBMET02361 0.173 0.054 DBMET02362 0.175 0.053 DBMET02370 0.437 0.006 DBMET02367 0.144 0.079 DBMET02369 | DBMET02361 | |
| 0.312 | 0.154 | 0.381 | Alpha-glucosidase inhibitor | 0.288 0.166 DBMET00759 0.381 0.123 DBMET02370 | DBMET02370 | |
| 0.147 | 0.024 | 0.173 | Estrogen antagonist | 0.158 0.021 DBMET00759 0.173 0.017 DBMET02361 0.127 0.043 DBMET02362 0.151 0.023 DBMET02370 0.146 0.025 DBMET02367 0.126 0.044 DBMET02369 | DBMET02361 | |
| 0.117 | 0.004 | 0.13 | Nitric oxide donor | 0.115 0.004 DBMET00759 0.13 0.003 DBMET02361 0.068 0.036 DBMET02362 0.109 0.005 DBMET02370 0.09 0.014 DBMET02367 | DBMET02361 | |
| 0.106 | 0.016 | 0.183 | Estrogen agonist | 0.112 0.015 DBMET00759 0.183 0.009 DBMET02361 0.067 0.027 DBMET02362 0.097 0.018 DBMET02370 0.123 0.014 DBMET02367 0.053 0.033 DBMET02369 | DBMET02361 | |
| 0.136 | 0.046 | 0.16 | Microtubule formation inhibitor | 0.16 0.033 DBMET00759 0.121 0.06 DBMET02361 0.119 0.062 DBMET02362 0.152 0.036 DBMET02370 0.118 0.063 DBMET02367 0.142 0.042 DBMET02369 | DBMET00759 | |
| 0.167 | 0.092 | 0.21 | Hepatoprotectant | 0.199 0.066 DBMET00759 0.202 0.064 DBMET02361 0.162 0.097 DBMET02362 0.147 0.113 DBMET02370 0.21 0.059 DBMET02367 0.142 0.119 DBMET02369 | DBMET02367 | |
| 0.104 | 0.037 | 0.173 | Interleukin 5 antagonist | 0.107 0.034 DBMET00759 0.173 0.008 DBMET02361 0.092 0.052 DBMET02362 0.083 0.066 DBMET02370 0.164 0.009 DBMET02367 | DBMET02361 | |
| 0.09 | 0.024 | 0.792 | Aromatase inhibitor | 0.087 0.025 DBMET00759 0.432 0.004 DBMET02361 0.379 0.004 DBMET02362 0.06 0.041 DBMET02370 0.792 0.002 DBMET02367 0.287 0.005 DBMET02369 | DBMET02367 | |
| 0.071 | 0.009 | 0.11 | RNA-directed RNA polymerase stimulant | 0.074 0.009 DBMET00759 0.11 0.005 DBMET02361 0.063 0.011 DBMET02362 0.064 0.01 DBMET02370 0.099 0.006 DBMET02367 0.055 0.012 DBMET02369 | DBMET02361 | |
| 0.069 | 0.012 | 0.269 | Progesterone antagonist | 0.059 0.015 DBMET00759 0.269 0.004 DBMET02361 0.058 0.015 DBMET02362 0.035 0.025 DBMET02370 0.254 0.004 DBMET02367 0.036 0.024 DBMET02369 | DBMET02361 | |
| 0.062 | 0.015 | 0.126 | 5-Alpha-reductase inhibitor | 0.078 0.013 DBMET00759 0.126 0.008 DBMET02361 0.044 0.021 DBMET02362 0.095 0.01 DBMET02367 | DBMET02361 | |
| 0.053 | 0.01 | 0.068 | Glucose-6-phosphate dehydrogenase inhibitor | 0.056 0.008 DBMET00759 0.068 0.005 DBMET02361 0.053 0.01 DBMET02362 0.035 0.033 DBMET02370 0.067 0.005 DBMET02367 | DBMET02361 | |
| 0.045 | 0.005 | 0.167 | Progesterone agonist | 0.046 0.005 DBMET00759 0.087 0.004 DBMET02361 0.13 0.003 DBMET02362 0.023 0.009 DBMET02370 0.167 0.003 DBMET02367 0.079 0.004 DBMET02369 | DBMET02367 | |
| 0.09 | 0.051 | 0.159 | Antineoplastic antibiotic | 0.106 0.043 DBMET00759 0.143 0.032 DBMET02361 0.095 0.049 DBMET02362 0.086 0.053 DBMET02370 0.159 0.029 DBMET02367 0.095 0.048 DBMET02369 | DBMET02367 | |
| 0.059 | 0.02 | 0.563 | Mineralocorticoid receptor antagonist | 0.06 0.02 DBMET00759 0.089 0.009 DBMET02361 0.464 0.003 DBMET02362 0.047 0.034 DBMET02370 0.563 0.002 DBMET02367 0.474 0.003 DBMET02369 | DBMET02367 | |
| 0.101 | 0.064 | 0.114 | Estrogen receptor beta antagonist | 0.107 0.051 DBMET00759 0.105 0.055 DBMET02361 0.099 0.066 DBMET02362 0.108 0.049 DBMET02370 0.114 0.039 DBMET02367 0.107 0.052 DBMET02369 | DBMET02367 | |
| 0.142 | 0.116 | 0.179 | 3C-like protease (Human coronavirus) inhibitor | 0.134 0.131 DBMET00759 0.179 0.066 DBMET02362 | DBMET02362 | |
| 0.111 | 0.1 | 0.266 | Interleukin 4 antagonist | 0.266 0.011 DBMET02361 0.225 0.017 DBMET02367 | DBMET02361 | |
| 0.057 | 0.056 | 0.067 | Heme oxygenase stimulant | 0.064 0.035 DBMET02361 0.061 0.043 DBMET02370 0.067 0.03 DBMET02367 0.058 0.051 DBMET02369 | DBMET02367 | |
| 0.005 | 0.005 | 0.022 | Transcortin receptor antagonist | 0.005 0.004 DBMET00759 0.022 0.001 DBMET02361 0.011 0.002 DBMET02367 | DBMET02361 | |
| 0.077 | 0.078 | 0.081 | 3C-Like protease (SARS coronavirus) inhibitor | 0.081 0.065 DBMET02362 | DBMET02362 | |
| 0.1 | 0.102 | 0.102 | Sphingosine 1-phosphate receptor 2 agonist | 0.102 0.096 DBMET02362 | DBMET02362 | |
| 0.01 | 0.015 | 0.013 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.008 DBMET02361 0.012 0.01 DBMET02362 0.013 0.006 DBMET02367 0.012 0.008 DBMET02369 | DBMET02367 | |
| 0.038 | 0.046 | 0.051 | Microtubule stabilization | 0.041 0.04 DBMET00759 0.046 0.033 DBMET02361 0.041 0.04 DBMET02362 0.051 0.026 DBMET02367 0.043 0.038 DBMET02369 | DBMET02367 | |
| 0.014 | 0.028 | 0.025 | Estrone sulfatase inhibitor | 0.024 0.013 DBMET02361 0.02 0.017 DBMET02370 0.025 0.012 DBMET02367 0.022 0.015 DBMET02369 | DBMET02367 | |
| 0.075 | 0.094 | 0.081 | Thioredoxin inhibitor | 0.081 0.079 DBMET00759 | DBMET00759 | |
| 0.017 | 0.037 | 0.056 | Estrogen receptor alpha agonist | 0.055 0.016 DBMET02361 0.056 0.016 DBMET02367 | DBMET02367 | |
| 0.071 | 0.096 | 0.085 | Thioredoxin reductase inhibitor | 0.085 0.049 DBMET02362 0.079 0.066 DBMET02367 0.077 0.069 DBMET02369 | DBMET02362 | |
| 0.108 | 0.136 | 0.152 | Farnesoid X receptor antagonist | 0.128 0.087 DBMET00759 0.126 0.091 DBMET02361 0.152 0.05 DBMET02370 0.128 0.087 DBMET02367 0.148 0.055 DBMET02369 | DBMET02370 | |
| 0.052 | 0.082 | 0.126 | Na+ K+ transporting ATPase inhibitor | 0.095 0.037 DBMET02361 0.099 0.033 DBMET02362 0.099 0.033 DBMET02370 0.125 0.014 DBMET02367 0.126 0.013 DBMET02369 | DBMET02369 | |
| 0.01 | 0.05 | 0.035 | Estrogen receptor beta agonist | 0.026 0.025 DBMET02361 0.035 0.022 DBMET02367 | DBMET02367 | |
| 0.089 | 0.132 | 0.18 | Lipid peroxidase inhibitor | 0.18 0.05 DBMET02361 0.171 0.055 DBMET02367 | DBMET02361 | |
| 0.059 | 0.109 | 0.075 | Estrogen receptor alpha antagonist | 0.075 0.058 DBMET02361 0.075 0.056 DBMET02367 | DBMET02367 | |
| 0.057 | 0.118 | 0.195 | Antineoplastic alkaloid | 0.075 0.072 DBMET00759 0.155 0.026 DBMET02361 0.092 0.053 DBMET02370 0.195 0.015 DBMET02367 0.14 0.03 DBMET02369 | DBMET02367 | |
| 0.069 | 0.131 | 0.171 | T cell inhibitor | 0.111 0.018 DBMET02361 0.087 0.045 DBMET02362 0.171 0.009 DBMET02367 | DBMET02367 | |
| 0.174 | 0.24 | 0.232 | Interleukin 2 agonist | 0.225 0.149 DBMET00759 0.232 0.14 DBMET02361 0.221 0.155 DBMET02370 0.214 0.166 DBMET02367 | DBMET02361 | |
| 0.115 | 0.22 | 0.231 | Antioxidant | 0.195 0.118 DBMET02361 0.231 0.095 DBMET02367 | DBMET02367 | |
| 0.062 | 0.187 | 0.097 | Toll-Like receptor 4 antagonist | 0.097 0.074 DBMET02367 | DBMET02367 | |
| 0.048 | 0.198 | 0.109 | Cholesterol synthesis inhibitor | 0.103 0.084 DBMET02361 0.109 0.076 DBMET02370 | DBMET02370 | |
| 0.036 | 0.195 | 0.106 | Glycine receptor antagonist | 0.101 0.031 DBMET02361 0.106 0.028 DBMET02367 | DBMET02367 | |
| 0.004 | 0.171 | 0.025 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.025 0.011 DBMET02367 | DBMET02367 | |
| 0.022 | 0.207 | 0.374 | Aldosterone antagonist | 0.074 0.013 DBMET02361 0.091 0.009 DBMET02362 0.374 0.002 DBMET02367 0.16 0.005 DBMET02369 | DBMET02367 | |
| 0.098 | 0.298 | 0.133 | CC chemokine 6 receptor antagonist | 0.133 0.06 DBMET02370 0.125 0.09 DBMET02369 | DBMET02370 | |
| 0.01 | 0.227 | 0.104 | Opioid kappa receptor agonist | 0.063 0.017 DBMET02362 0.065 0.016 DBMET02367 0.104 0.009 DBMET02369 | DBMET02369 | |
| 0.101 | 0.33 | 0.243 | Cholesterol antagonist | 0.243 0.131 DBMET02370 0.231 0.139 DBMET02369 | DBMET02370 | |
| 0.048 | 0.328 | 0.241 | Anesthetic general | 0.241 0.054 DBMET02361 0.19 0.08 DBMET02367 | DBMET02361 | |
| 0.049 | 0.41 | 0.562 | Interleukin 6 antagonist | 0.419 0.006 DBMET02362 0.562 0.004 DBMET02367 0.455 0.005 DBMET02369 | DBMET02367 | |
| 0.02 | 0.509 | 0.082 | Opioid kappa receptor antagonist | 0.082 0.055 DBMET02367 0.074 0.067 DBMET02369 | DBMET02367 | |
| 0.039 | 0.577 | 0.236 | Neurotrophic factor enhancer | 0.236 0.047 DBMET02367 | DBMET02367 | |
| 0.047 | 0.603 | 0.185 | RNA-directed DNA polymerase inhibitor | 0.185 0.124 DBMET02370 0.173 0.145 DBMET02369 | DBMET02370 | |
| 0.015 | 0.608 | 0.128 | Thrombolytic | 0.128 0.101 DBMET02367 | DBMET02367 | |
| 0.015 | 0.667 | 0.115 | Interleukin 8 antagonist | 0.115 0.069 DBMET02361 | DBMET02361 | |
| 0.005 | 0.709 | 0.325 | Diuretic | 0.156 0.073 DBMET02362 0.325 0.019 DBMET02367 0.277 0.027 DBMET02369 | DBMET02367 | |
| 0.012 | 0.745 | 0.409 | Interleukin antagonist | 0.409 0.029 DBMET02367 | DBMET02367 | |
| 0.005 | 0.864 | 0.178 | Transcription factor STAT3 inhibitor | 0.178 0.167 DBMET02369 | DBMET02369 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |